Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.10 -0.04 (-3.51%)
As of: Sep 30, 2026 · 10:05 AM EDT

Actinium Pharmaceuticals (ATNM) EV to EBITDA (2026)

Updated

Actinium Pharmaceuticals' EV to EBITDA was -0.58 in Q2 2026.

Analysis

Actinium Pharmaceuticals (ATNM) EV to EBITDA (2026) Analysis & Trends

On a trailing twelve-month basis, Actinium Pharmaceuticals' EV to EBITDA was -15.25 through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Actinium Pharmaceuticals 37.10 Mn 37.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.58
API Access

Actinium Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ATNM&period=max&api_key=YOUR_API_KEY